Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T...
Thus far, all approved chimeric antigen receptor (CAR)-T products are manufactured using modified viruses, which increases the risk of tumorigenesis, costs and production time. We aimed to evaluate...
pmc.ncbi.nlm.nih.gov